DiaSorin S.p.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
434,849.00
443,770.00
499,181.00
569,312.00
637,487.00
669,197
Cost of Goods Sold (COGS) incl. D&A
143,056.00
153,223.00
164,675.00
198,729.00
225,094.00
234,956
Gross Income
291,793.00
290,547.00
334,506.00
370,583.00
412,393.00
434,241
SG&A Expense
152,216.00
157,255.00
175,134.00
189,567.00
211,997.00
223,828
EBIT
135,307.00
130,562.00
156,365.00
175,679.00
198,188.00
208,552
Unusual Expense
229.00
2,681.00
2,108.00
5,426.00
12,022.00
1,709
Non Operating Income/Expense
3,190.00
1,442.00
3,220.00
532.00
4,146.00
468
Interest Expense
2,853.00
2,467.00
2,282.00
3,105.00
4,133.00
4,318
Pretax Income
129,822.00
128,489.00
150,533.00
168,751.00
179,110.00
204,508
Income Tax
46,228.00
44,050.00
49,554.00
55,578.00
38,828.00
46,235
Equity in Affiliates
483.00
365.00
431.00
555.00
404.00
143
Consolidated Net Income
83,111.00
84,074.00
100,548.00
112,618.00
139,878.00
158,130
Net Income
83,028.00
84,074.00
100,420.00
112,383.00
139,878.00
158,128
Net Income After Extraordinaries
83,028.00
84,074.00
100,420.00
112,383.00
139,878.00
158,128
Net Income Available to Common
83,028.00
84,074.00
100,420.00
112,383.00
139,878.00
158,128
EPS (Basic)
1.53
1.55
1.83
2.05
2.54
2.85
Basic Shares Outstanding
54,357.50
54,400.80
54,883.50
54,849.90
54,997.40
55,513.10
EPS (Diluted)
1.53
1.55
1.83
2.04
2.54
2.85
Diluted Shares Outstanding
54,357.50
54,400.80
54,883.50
55,089.70
54,997.40
55,513.10
EBITDA
163,712.00
160,961.00
189,349.00
220,386.00
244,039.00
253,927
Other Operating Expense
4,270.00
2,730.00
3,007.00
5,337.00
2,208.00
1,861
Non-Operating Interest Income
787.00
1,633.00
1,778.00
1,071.00
1,223.00
1,515
Minority Interest Expense
83.00
-
128.00
235.00
-
2

About DiaSorin

View Profile
Address
Via Crescentino snc
Saluggia Vercelli 13040
Italy
Employees -
Website http://www.diasorin.com
Updated 07/08/2019
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy .